ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,268,000 | -41.7% | 178,150 | -33.8% | 0.17% | -43.5% |
| Q2 2022 | $2,176,000 | -11.1% | 268,925 | +52.5% | 0.29% | -5.8% |
| Q1 2022 | $2,448,000 | +34.4% | 176,342 | +171.7% | 0.31% | +21.9% |
| Q4 2021 | $1,821,000 | +74.8% | 64,899 | +268.3% | 0.26% | +54.2% |
| Q4 2020 | $1,042,000 | -9.5% | 17,623 | -25.5% | 0.17% | -21.3% |
| Q3 2020 | $1,151,000 | +264.2% | 23,666 | +261.7% | 0.21% | +744.0% |
| Q2 2019 | $316,000 | – | 6,543 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |